Dodla Dairy Limited — Quarter and year ended 31 March 2026
| Particulars | 31-Mar-26 | 31-Dec-25 | 31-Mar-25 | 31-Mar-26 | 31-Mar-25 |
|---|---|---|---|---|---|
| Audited | Unaudited | Audited | Audited | Audited | |
| 1. INCOME | |||||
| a) Revenue from operations | 8,449.16 | 8,215.26 | 8,078.65 | 34,216.99 | 33,415.28 |
| b) Other income | 192.08 | 115.85 | 244.10 | 711.44 | 706.41 |
| Total income [a+b] | 8,641.24 | 8,331.11 | 8,322.75 | 34,928.43 | 34,121.69 |
| 2. EXPENSES | |||||
| a) Cost of materials consumed | 6,460.06 | 6,165.19 | 5,495.06 | 25,556.78 | 22,386.99 |
| b) (Increase)/decrease in inventories of finished goods and work-in-progress | 226.43 | 33.32 | 508.71 | 444.22 | 2,323.56 |
| c) Employee benefits expense | 412.77 | 419.13 | 360.97 | 1,665.58 | 1,414.88 |
| d) Finance costs | 4.29 | 3.01 | 3.09 | 13.44 | 11.73 |
| e) Depreciation and amortisation expense | 156.99 | 156.49 | 155.68 | 617.06 | 643.57 |
| f) Other expenses | 1,060.32 | 1,028.09 | 1,042.91 | 4,307.99 | 4,098.25 |
| Total expenses | 8,320.86 | 7,805.23 | 7,566.42 | 32,605.07 | 30,878.98 |
| 3. Profit before exceptional items and tax [1-2] | 320.38 | 525.88 | 756.33 | 2,323.36 | 3,242.71 |
| 4. Exceptional items (refer note 5) | 32.76 | (56.27) | – | (23.51) | – |
| 5. Profit before tax [3+4] | 353.14 | 469.61 | 756.33 | 2,299.85 | 3,242.71 |
| 6. Tax expense/(credit) | |||||
| a) Current tax | 76.28 | 124.99 | 141.12 | 596.22 | 743.54 |
| b) Adjustment of tax relating to earlier years (refer note 6) | (291.57) | (218.24) | – | (529.00) | – |
| c) Deferred tax | 13.89 | (5.14) | 48.18 | (51.21) | 29.35 |
| Total tax expense/(credit) | (201.40) | (98.39) | 189.30 | 16.01 | 772.89 |
| 7. Profit for the period/year [5-6] | 554.54 | 568.00 | 567.03 | 2,283.84 | 2,469.82 |
| 8. Other comprehensive income | |||||
| Items that will not be reclassified subsequently to statement of profit and loss | |||||
| Remeasurement (loss)/gain on the net defined benefit obligation | (1.38) | (4.03) | (4.84) | (17.39) | (13.10) |
| Income tax on above | 0.35 | 1.02 | 1.22 | 4.38 | 3.30 |
| Other comprehensive (loss)/income for the period/year, net of tax | (1.03) | (3.01) | (3.62) | (13.01) | (9.80) |
| 9. Total comprehensive income for the period/year, net of tax [7+8] | 553.51 | 564.99 | 563.41 | 2,270.83 | 2,460.02 |
| 10. Paid-up equity share capital (Face value of ₹ 10 each) | 603.28 | 603.28 | |||
| 11. Other equity | 14,369.20 | 12,219.03 | |||
| 12. Earnings per share (Face value of ₹ 10 each) (not annualised for the quarters) | |||||
| a) Basic (in ₹) | 9.19 | 9.42 | 9.40 | 37.86 | 41.11 |
| b) Diluted (in ₹) | 9.19 | 9.42 | 9.40 | 37.86 | 41.11 |
| Particulars | As at 31-Mar-26 Audited | As at 31-Mar-25 Audited |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Property, plant and equipment | 5,582.94 | 5,410.47 |
| Capital work-in-progress | 985.64 | 108.79 |
| Goodwill | 433.37 | 433.37 |
| Other intangible assets | 24.11 | 29.07 |
| Right-of-use assets | 132.69 | 108.85 |
| Biological assets other than bearer plants | ||
| (i) Matured biological assets | 5.15 | 6.13 |
| (ii) Immatured biological assets | 2.98 | 2.38 |
| Financial assets | ||
| (i) Investments | 3,848.92 | 544.55 |
| (ii) Loans | 212.72 | 249.48 |
| (iii) Other financial assets | 162.67 | 145.33 |
| Non-current tax asset (net) | 260.49 | 50.77 |
| Other non-current assets | 81.62 | 86.97 |
| Total non-current assets | 11,733.30 | 7,176.16 |
| Current assets | ||
| Inventories | 910.56 | 1,194.06 |
| Financial assets | ||
| (i) Investments | 3,172.89 | 6,251.10 |
| (ii) Trade receivables | 112.88 | 119.29 |
| (iii) Cash and cash equivalent | 452.44 | 451.08 |
| (iv) Bank balances other than (iii) above | 1,070.31 | 0.27 |
| (v) Loans | 36.76 | 36.76 |
| (vi) Other financial assets | 162.50 | 63.16 |
| Other current assets | 59.34 | 61.82 |
| Total current assets | 5,977.68 | 8,177.54 |
| Total assets | 17,710.98 | 15,353.70 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 603.28 | 603.28 |
| Other equity | 14,369.20 | 12,219.03 |
| Total equity | 14,972.48 | 12,822.31 |
| Liabilities | ||
| Non-current liabilities | ||
| Financial liabilities | ||
| (i) Lease liabilities | 119.90 | 97.25 |
| (ii) Other financial liabilities | 1.71 | 2.64 |
| Provisions | 202.02 | 140.54 |
| Government grants | 11.48 | 13.94 |
| Deferred tax liabilities (net) | 122.05 | 177.63 |
| Total non-current liabilities | 457.16 | 432.00 |
| Current liabilities | ||
| Financial liabilities | ||
| (i) Lease liabilities | 38.32 | 34.67 |
| (ii) Trade payables | ||
| (a) Total outstanding dues of micro enterprises and small enterprises; and | 88.48 | 51.46 |
| (b) Total outstanding dues of creditors other than micro enterprises and small enterprises | 1,251.45 | 1,197.93 |
| (iii) Other financial liabilities | 757.74 | 480.44 |
| Government grants | 2.68 | 2.95 |
| Other current liabilities | 85.43 | 107.91 |
| Provisions | 57.24 | 69.79 |
| Current tax liabilities (net) | – | 154.24 |
| Total current liabilities | 2,281.34 | 2,099.39 |
| Total liabilities | 2,738.50 | 2,531.39 |
| Total equity and liabilities | 17,710.98 | 15,353.70 |
| Particulars | Year ended 31-Mar-26 (Audited) | Year ended 31-Mar-25 (Audited) |
|---|---|---|
| Cash flows from operating activities | ||
| Profit before tax | 2,299.85 | 3,242.71 |
| Adjustments to reconcile profit before tax to net cash flows: | ||
| – Depreciation and amortisation expense | 617.06 | 643.57 |
| – Changes in fair value of biological assets | (1.46) | (2.28) |
| – (Profit)/loss on sale/retirement of property, plant and equipment, net | (0.86) | 5.32 |
| – Loss on sale/discard of biological assets, net | 0.96 | 1.60 |
| – Interest income | (225.94) | (76.20) |
| – Finance costs | 13.44 | 11.73 |
| – Dividend from subsidiary | (122.90) | (181.76) |
| – Profit on sale of investments in mutual funds, net | (217.31) | (110.56) |
| – Fair value gain on financial assets measured at fair value through profit and loss | (48.22) | (162.84) |
| – Impairment reversal on doubtful advances, net | (1.54) | (2.35) |
| – Impairment (reversal)/allowance on trade receivables, net | (8.03) | 9.83 |
| – Bad debts written off | 3.39 | 1.86 |
| – Amortisation of government grants | (2.73) | (2.85) |
| – Gain on account of foreign exchange fluctuations, net | (0.83) | (0.08) |
| – Liabilities no longer required, written back | (25.41) | (94.71) |
| Operating profit before working capital changes | 2,279.47 | 3,282.99 |
| Working capital adjustments | ||
| Decrease/(increase) in trade receivables | 11.88 | (42.41) |
| Decrease in inventories | 283.50 | 2,359.75 |
| Decrease/(increase) in other financial assets | 35.29 | (5.38) |
| (Increase)/decrease in other current and non-current assets | (6.00) | 33.95 |
| Increase/(decrease) in trade payables and other financial liabilities | 126.25 | (31.47) |
| Increase in provisions | 31.54 | 29.48 |
| (Decrease)/increase in other current and non-current liabilities | (22.49) | 23.48 |
| Cash generated from operations | 2,739.44 | 5,650.39 |
| Income taxes paid, net | (405.76) | (861.23) |
| Net cash from operating activities | 2,333.68 | 4,789.16 |
| Cash flows from investing activities | ||
| Acquisition of property, plant and equipment and intangible assets | (1,390.07) | (876.44) |
| Proceeds from sale of property, plant and equipment | 13.11 | 19.37 |
| Proceeds from sale of biological assets | 0.12 | 1.24 |
| Loans given to subsidiary | – | (12.50) |
| Loans repaid by subsidiary | 36.76 | 36.76 |
| Dividend received from subsidiary | 122.90 | 181.76 |
| Investment in subsidiary | (2,710.00) | – |
| Purchase of investments (mutual funds and bonds) | (16,783.51) | (19,861.60) |
| Proceeds from sale of investments (mutual funds and bonds) | 19,532.89 | 15,716.24 |
| Interest received | 173.82 | 99.11 |
| Investment in bank deposits (having original maturity of more than three months) | (1,169.89) | (0.30) |
| Net cash used in investing activities | (2,173.87) | (4,696.36) |
| Cash flows from financing activities | ||
| Issue of shares | – | 178.19 |
| Payment of principal portion of lease liabilities | (24.35) | (20.53) |
| Interest on lease liabilities | (13.44) | (11.73) |
| Payment of dividend | (120.66) | (180.98) |
| Net cash used in financing activities | (158.45) | (35.05) |
| Net increase in cash and cash equivalents | 1.36 | 57.75 |
| Cash and cash equivalents at the beginning of the year | 451.08 | 393.33 |
| Cash and cash equivalents at end of the year (refer note below) | 452.44 | 451.08 |
| Particulars | As at 31-Mar-26 | As at 31-Mar-25 |
|---|---|---|
| Balances with banks | ||
| – in current accounts | 444.27 | 420.02 |
| – in deposit accounts (with original maturity of less than three months) | 1.00 | – |
| Cash on hand | 7.17 | 31.06 |
| Total | 452.44 | 451.08 |
| Particulars | Quarter ended 31-Mar-26 (Audited) | 31-Dec-25 (Unaudited) | 31-Mar-25 (Audited) | Year ended 31-Mar-26 (Audited) | 31-Mar-25 (Audited) |
|---|---|---|---|---|---|
| 1. INCOME | |||||
| a) Revenue from operations | 10,744.72 | 10,250.41 | 9,096.23 | 41,252.01 | 37,200.65 |
| b) Other income | 201.64 | 119.10 | 257.92 | 603.70 | 532.94 |
| Total income [a+b] | 10,946.36 | 10,369.51 | 9,354.15 | 41,855.71 | 37,733.59 |
| 2. EXPENSES | |||||
| a) Cost of materials consumed | 8,049.30 | 7,554.81 | 6,133.18 | 30,279.48 | 24,670.10 |
| b) Purchase of stock-in-trade | – | – | – | 3.24 | – |
| c) (Increase)/decrease in inventories of finished goods, work-in-progress and stock-in-trade | 228.60 | 30.18 | 491.33 | 421.25 | 2,319.52 |
| d) Employee benefits expense | 516.70 | 522.40 | 406.13 | 2,009.69 | 1,599.15 |
| e) Finance costs | 9.91 | 8.41 | 8.70 | 33.44 | 37.06 |
| f) Depreciation and amortisation expense | 219.94 | 219.75 | 181.63 | 823.35 | 746.34 |
| g) Other expenses | 1,412.41 | 1,349.45 | 1,230.32 | 5,453.83 | 4,803.64 |
| Total expenses | **10 |